EASE TRICUSPID Expertise-based Assessment Study on Clinical Efficacy of Contour 3D® in TRICUSPID Valve Annuloplasty
Sponsor: Medtronic Cardiac Rhythm and Heart Failure
Listed as NCT01532921, this observational or N/A phase trial focuses on Tricuspid Valve Insufficiency and remains completed. Sponsored by Medtronic Cardiac Rhythm and Heart Failure, it has been updated 8 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Jul 2025 — Present [monthly]
Completed
-
Sep 2024 — Jul 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Sep 2018 — Jan 2021 [monthly]
Completed
▶ Show 3 earlier versions
-
Jun 2018 — Sep 2018 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Jan 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Medtronic Cardiac Rhythm and Heart Failure
For direct contact, visit the study record on ClinicalTrials.gov .